Yanting Zhou

2.2k total citations
37 papers, 419 citations indexed

About

Yanting Zhou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yanting Zhou has authored 37 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Yanting Zhou's work include Metabolomics and Mass Spectrometry Studies (4 papers), Ubiquitin and proteasome pathways (4 papers) and Mitochondrial Function and Pathology (3 papers). Yanting Zhou is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (4 papers), Ubiquitin and proteasome pathways (4 papers) and Mitochondrial Function and Pathology (3 papers). Yanting Zhou collaborates with scholars based in China, Ethiopia and United States. Yanting Zhou's co-authors include Hu Zhou, Weigang Fang, Xin‐Xia Tian, Hui Yang, Han Yang, Hongquan Zhang, Yuqiu Wang, Xiao Xiao, Huiying He and Xiangling Chen and has published in prestigious journals such as Circulation, Analytical Chemistry and Oncogene.

In The Last Decade

Yanting Zhou

30 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanting Zhou China 11 257 101 83 41 32 37 419
Roseline Guibon France 12 198 0.8× 88 0.9× 42 0.5× 83 2.0× 60 1.9× 20 428
Frances F. Diehl United States 7 372 1.4× 249 2.5× 63 0.8× 13 0.3× 27 0.8× 8 517
Erika Baldoli Italy 7 154 0.6× 48 0.5× 83 1.0× 20 0.5× 18 0.6× 11 421
Pengkai Sun China 9 258 1.0× 107 1.1× 42 0.5× 17 0.4× 42 1.3× 16 488
Ya Chun Wu Hong Kong 11 317 1.2× 55 0.5× 82 1.0× 36 0.9× 170 5.3× 13 546
Matthew Sullivan United States 12 303 1.2× 44 0.4× 51 0.6× 10 0.2× 34 1.1× 21 510
Linwei Li China 13 278 1.1× 109 1.1× 21 0.3× 14 0.3× 14 0.4× 26 447
Junfei Jin China 12 318 1.2× 60 0.6× 55 0.7× 12 0.3× 75 2.3× 21 461
Ahmet Alptekin United States 13 284 1.1× 176 1.7× 44 0.5× 8 0.2× 22 0.7× 27 483

Countries citing papers authored by Yanting Zhou

Since Specialization
Citations

This map shows the geographic impact of Yanting Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanting Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanting Zhou more than expected).

Fields of papers citing papers by Yanting Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanting Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanting Zhou. The network helps show where Yanting Zhou may publish in the future.

Co-authorship network of co-authors of Yanting Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yanting Zhou. A scholar is included among the top collaborators of Yanting Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanting Zhou. Yanting Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Qiwen, Tao Zhou, Yanting Zhou, et al.. (2025). Discovery of tetracyclic 1,2,4-triazoline-fused dibenzo[b,f][1,4]oxazepine as a potent anti-colorectal cancer agent with good efficacy and low toxicity. Bioorganic & Medicinal Chemistry. 125. 118203–118203.
3.
Cao, Fei, Yanting Zhou, Yixi Xie, et al.. (2025). A novel electrochemical sensor based on hollow porous heterojunction Ti3C2Tx/Ni(OH)2@MWCNTs for the determination of hydroquinone. Microchemical Journal. 219. 116157–116157.
4.
Wang, Yirong, et al.. (2024). Preparation of silk fibroin‐derived hydrogels and applications in skin regeneration. Health Science Reports. 7(8). e2295–e2295. 8 indexed citations
5.
Qiao, Jing, Wenjie Gong, Ruihong Zhang, et al.. (2024). Spatial metabolomics highlights metabolic reprogramming in acute myeloid leukemia mice through creatine pathway. Acta Pharmaceutica Sinica B. 14(10). 4461–4477. 6 indexed citations
6.
Chen, Lulin, Yanting Zhou, & Wei Liu. (2024). Assessment of resident physicians satisfaction on residency training in Southwest China:A cross-sectional study. Clinical Epidemiology and Global Health. 30. 101802–101802. 1 indexed citations
8.
Zhou, Yanting, Qiheng Li, Ruihong Zhang, et al.. (2024). SIRT1 Ameliorates Lamin A/C Deficiency-Induced Cardiac Dysfunction by Promoting Mitochondrial Bioenergetics. JACC Basic to Translational Science. 9(10). 1211–1230.
9.
Yu, Siyuan, et al.. (2023). Rapid fabrication of monodisperse PMMA microspheres through dispersion photopolymerization under green LED irradiation. Reactive and Functional Polymers. 188. 105594–105594. 4 indexed citations
10.
Shi, Mingsong, Xinyu Zhang, Meng Du, et al.. (2023). Interactions between curcumin and human salt-induced kinase 3 elucidated from computational tools and experimental methods. Frontiers in Pharmacology. 14. 1116098–1116098. 2 indexed citations
12.
Yang, Han, Yuntao Xie, Jovia L. Nierenberg, et al.. (2022). The risk variant rs11836367 contributes to breast cancer onset and metastasis by attenuating Wnt signaling via regulatingNTN4expression. Science Advances. 8(23). eabn3509–eabn3509. 4 indexed citations
13.
Wang, Yuqiu, Minhua Hong, Yanting Zhou, et al.. (2021). Quantitative proteomic analysis uncovers inhibition of melanin synthesis by silk fibroin via MITF/tyrosinase axis in B16 melanoma cells. Life Sciences. 284. 119930–119930. 13 indexed citations
14.
Yang, Hui, Han Yang, Yanting Zhou, et al.. (2020). Extracellular ATP promotes breast cancer invasion and chemoresistance via SOX9 signaling. Oncogene. 39(35). 5795–5810. 43 indexed citations
15.
Wang, Yuqiu, et al.. (2020). Metaproteomics: A strategy to study the taxonomy and functionality of the gut microbiota. Journal of Proteomics. 219. 103737–103737. 58 indexed citations
16.
Yu, Yue, Sai Tian, Yanting Zhou, et al.. (2020). Quantitative proteomics reveals Shexiang Baoxin Pill exerts cardioprotective effects by preserving energy metabolism in a rat model of myocardial infarction. Journal of Ethnopharmacology. 266. 113460–113460. 12 indexed citations
17.
Zhou, Yanting, Ying Feng, Lin Zhang, et al.. (2019). In Vitro and In Vivo Study on the Effect of Lysosome-associated Protein Transmembrane 4 Beta on the Progression of Breast Cancer. Journal of Breast Cancer. 22(3). 375–375. 3 indexed citations
18.
Wu, Jian, Hongwen Zhu, Yanting Zhou, et al.. (2019). Uncovering kappa-opioid receptor agonist-induced PAK1/2 phosphorylation by quantitative phosphoproteomics. Biochemical and Biophysical Research Communications. 516(1). 320–326. 4 indexed citations
19.
Chen, Xiangling, Jing Gao, Hongwen Zhu, et al.. (2018). A novel USP9X substrate TTK contributes to tumorigenesis in non-small-cell lung cancer. Theranostics. 8(9). 2348–2360. 58 indexed citations
20.
Gao, Jing, et al.. (2016). Deep Phosphoproteomic Measurements Pinpointing Drug Induced Protective Mechanisms in Neuronal Cells. Frontiers in Physiology. 7. 635–635. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026